An Improved Adaptive Neuro-fuzzy Inference Framework for Lung Cancer Detection and Prediction on Internet of Medical Things Platform
It has become increasingly difficult for medical practitioners to recognize illness in recent years due to the emergence of new diseases from their myriad causes on a daily basis. Due in large part to inadequate diagnostic and monitoring infrastructure, a substantial amount of illness and death are associated with lung cancer (LC). The aim of the paper is to find lung cancer early and help patients receive curative treatment. Quitting smoking or never starting is the best way to mitigate the potential for disease-related death. As a result, cutting-edge detection and monitoring technologies must be developed to enable rapid, accurate, and timely diagnosis. Fuzzy logic (FL) is one of the best approaches to modeling complex and uncertain systems; therefore, it helps us deal with these challenges. Fuzzy expert system for lung cancer [FES-LC] detection and prediction on Internet of medical things (IoMT) is employed to overcome the challenges. Hence, an enhanced adaptive neuro-fuzzy inference framework [ANF-IF] is proposed in the current research. The cloud-based application of an adaptive neuro-fuzzy inference system yields four risk categories: not at risk, slightly at risk, moderately at risk, and severely at risk. New methods and theoretical frameworks have made it possible to diagnose LC in its earliest stages with the help of magnetic nanoparticles (MNPs), which allow researchers to overcome the limitations of conventionally slow diagnostic efficiency. The proposed system exhibits a precision of 93.4%, accuracy of 95.1%, specificity of 90.6%, sensitivity of 92.8%, false positive rate of 0.22%, false negative ratio of 0.18%, and classification accuracy of 98.2%. The proposed method outperforms all methods and provides better lung cancer detection accuracy than others.